Welcome to Good News about Mannatech

The goal of this blog is to share positive press regarding Mannatech's products, science, research and people.

All comments will be moderated.

Please post photos of Optimal Skin Care, before and after photos.

Any quoted material, please reference the source of the material.

*These statements have not
been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Saturday, October 4, 2008

10 Best Stocks ... Cheap!

This portion of an article recently published on Fool.com an investing education website.

You can see Mannatech's stock listed here for the potential growth it has and the low price of the stock currently. Definitely interesting, as Mannatech has been listed as a hot stock buy multiple times, and each time the company grows. Now operating in 11 countries and soon to open in Mexico as well as other Asian countries. This stock is expected to grow by many experts.

-----------------------------------

"... is clearly a universe of stocks with a lot of potential, as well as one ripe with inefficiencies ... as you can see from this comparison of the institutional ownership and analyst coverage for "ownable" large caps …

Company

Market Cap

Recent Price

Institutional Ownership

No. of Analysts Following

Adobe Systems (Nasdaq: ADBE)

$21 billion

$38.85

88%

25

Gilead Sciences (Nasdaq: GILD)

$43 billion

$44.69

96%

29

Target (NYSE: TGT)

$38 billion

$49.51

110%*

22

*Total Shares Outstanding can exceed 100% because reporting requirements for holdings data is not aligned with the financials reporting of shares outstanding.

... versus "un-ownable" small caps:

Company

Market Cap

Recent Price

Institutional Ownership

No. of Analysts Following

Books-A-Million

$97 million

$6.24

35%

0

Mannatech (Nasdaq: MTEX)

$105 million

$3.95

31%

0

ChinaHousing and Land

$62 million

$2.04

15%

1

Data from Capital IQ and Thomson Financial.

Potential and inefficiency. Put those traits together in the stock market, and -- as Fidelity and Royce have proved -- you can make a lot of money.

No comments: